RACHEL LINER: Open Payments
NPI 1952878340 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 30 payments from 9 companies in 2025. Trend: 2023 $712 · 2024 $620 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $187 |
| Vanda Pharmaceuticals Inc. | 2 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $62 |
| Lundbeck LLC | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Alkermes, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, FANAPT, REXULTI, INGREZZA, COBENFY, CAPLYTA, ARISTADA, TRINTELLIX.
Industry payments across AL — which companies pay providers there.
